Wird geladen...

Review of Venetoclax in CLL, AML and Multiple Myeloma

Venetoclax is a highly selective and effective B-cell lymphoma-2 (BCL-2) inhibitor, which is able to reinstate the apoptotic potential of cancer cells. With its full repertoire yet to be explored, it has changed the therapeutic landscape in haematological malignancies, and most particularly chronic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Pers Med
Hauptverfasser: Lasica, Masa, Anderson, Mary Ann
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8225137/
https://ncbi.nlm.nih.gov/pubmed/34073976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060463
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!